You are viewing: US Cold Plasma Market analysis
Part of: Cold Plasma Market (Global)

The US Cold Plasma Market was valued at $310.31 Million in 2024 and projected to reach to $509.51 Million by 2029, representing a compound annual growth rate of CAGR 10.4%. The US cold plasma market is positioned for sustained expansion through 2029, with the projected market size reaching $509.51 million representing a 64% increase from 2024 levels.

US Cold Plasma Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Cold Plasma Market Trends and Insights

  • The US healthcare sector is increasingly adopting cold plasma technology for wound healing, sterilization, and dermatological applications, driven by rising demand for minimally invasive treatment options.
  • The US market's 10.4% compound annual growth rate reflects strong clinical adoption and regulatory support within the country's advanced healthcare infrastructure. In the US, cold plasma adoption is accelerating across hospitals, surgical centers, and specialty clinics as healthcare providers recognize its efficacy in infection control and tissue regeneration.
  • The US regulatory environment, supported by FDA oversight and clinical validation, has bolstered confidence in cold plasma devices among US healthcare practitioners.
  • Between 2024 and 2029, the US market is expected to capture significant share growth as US manufacturers expand production capacity and US healthcare systems integrate cold plasma into standard treatment protocols..

Key Market Statistics

  • CAGR (2024-2029) CAGR 10.4%
  • Market Size, 2024 ~USD 310.31 Million
  • Forecast, 2029 ~USD 509.51 Million
  • Country US

US Cold Plasma Market Overview

Market Valuation :

The US cold plasma market reached $310.31 million in 2024, demonstrating strong market penetration across healthcare facilities and clinical settings nationwide.

Robust Growth Trajectory :

With a 10.4% CAGR through 2029, the US market is expanding faster than many competing medical technologies, reflecting accelerating adoption rates among US healthcare providers.

Clinical Application Expansion :

US hospitals and clinics are increasingly deploying cold plasma for wound healing, surgical sterilization, and dermatological treatments, driven by proven efficacy and minimally invasive benefits.

Minimally Invasive Preference :

Rising US patient demand for non-invasive treatment options and reduced recovery times is propelling cold plasma adoption across major healthcare systems and outpatient facilities.

US Cold Plasma Market Dynamics

  • This growth is underpinned by increasing FDA approvals, expanding clinical evidence supporting efficacy, and growing integration into US hospital protocols.
  • Healthcare providers are recognizing cold plasma's versatility across multiple therapeutic areas, from chronic wound management to surgical site sterilization. Key drivers include the US healthcare system's shift toward value-based care, patient preference for minimally invasive procedures, and rising healthcare expenditures supporting advanced technology adoption.
  • Regulatory support and reimbursement improvements are expected to accelerate market penetration, particularly in outpatient and specialty care settings across major US metropolitan areas..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The US cold plasma market is valued at $310.31 million in 2024 and will reach $509.51 million by 2029, representing a 10.4% CAGR.
    • US healthcare providers are rapidly adopting cold plasma for wound care, sterilization, and dermatological treatments due to minimally invasive benefits.
    • The US regulatory framework and FDA approval pathways are accelerating clinical adoption and market expansion across US medical institutions.
    • US manufacturers are scaling production to meet growing demand, positioning the country as a key hub for cold plasma technology development and deployment.

    Cold Plasma Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment MEDICAL INDUSTRY (Industry)
    Forecast Period 2024-2029
    Growth Rate CAGR of 11% from 2024 to 2029
    Largest Segment ATMOSPHERIC COLD PLASMA (Regime)
    Market Size Base Year (Billions) ~USD 2.14 (2024)
    Revenue Forecast (Billions) ~USD 3.6 (2029)
    Segments Covered Industry, Application, Regime

    US Cold Plasma Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Industry

    • Cosmetic Industry
    • Electronics & Semiconductors Industry
    • Food & Agriculture Industry
    • Medical Industry
    • Other Industries
    • Polymer & Plastic Industry
    • Textile Industry

    By Application

    • Aesthetic Procedures
    • Coating & Thin-Film Deposition
    • Other Applications
    • Printing
    • Surface Cleaning & Decontamination
    • Surface Etching
    • Surface Treatment & Activation
    • Surgical
    • Wound Healing

    By Regime

    • Atmospheric Cold Plasma
    • Low-Pressure Cold Plasma

    US: COLD PLASMA MARKET, BY INDUSTRY, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    COSMETIC INDUSTRY22.423.324.826.828.831.434.638.29.1
    ELECTRONICS & SEMICONDUCTORS INDUSTRY135142.9154.7170.3187207.5232.3261.311.1
    FOOD & AGRICULTURE INDUSTRY53.155.759.765.170.877.886.396.210
    MEDICAL INDUSTRY61.166.173.282.392.4104.812013813.5
    OTHER INDUSTRIES9.910.210.711.512.213.114.315.610
    POLYMER & PLASTIC INDUSTRY273.9288.3310.3339.6370.8409.1455.5509.510.4
    TEXTILE INDUSTRY184.9193.2206.4224.1242.9265.9293.8326.29.6
    TOTAL740.3779.8839.8919.710051109.71236.8138510.5

    Target Audience

    • Medical Device Manufacturers : Evaluate US market opportunity for cold plasma device development and commercialization, with specific sizing data to support R&D investment and launch planning decisions.
    • Healthcare System Executives : Assess cold plasma technology adoption potential within your US hospital network, understanding market trends and clinical ROI to guide capital equipment procurement strategies.
    • Investment & Private Equity Firms : Identify high-growth US cold plasma companies and market segments for acquisition or funding, backed by validated market sizing and 5-year growth projections.
    • Healthcare Consultants & Advisors : Support client strategy development with authoritative US cold plasma market data, competitive positioning analysis, and clinical adoption forecasts for advisory engagements.
    • Regulatory & Compliance Officers : Monitor US market dynamics, reimbursement trends, and regulatory developments affecting cold plasma commercialization and market access strategies.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Confirm the US cold plasma market's $310.31M valuation and 10.4% CAGR trajectory through 2029, providing data-driven confidence for investment and expansion decisions.
    • US-Specific Clinical Insights : Access detailed analysis of cold plasma adoption patterns across US wound care, surgical sterilization, and dermatology segments to identify high-opportunity clinical verticals.
    • Competitive Positioning Strategy : Benchmark your US market position against competitors with country-specific data on adoption rates, reimbursement trends, and healthcare provider preferences.
    • Regulatory & Reimbursement Landscape : Understand US FDA approval pathways, insurance coverage evolution, and reimbursement dynamics shaping market accessibility and revenue potential through 2029.
    • Strategic Market Entry Planning : Leverage US-focused forecasts and regional healthcare system insights to develop targeted go-to-market strategies and identify priority geographic markets for expansion.

    Frequently asked questions

    What is the current size of the US cold plasma market?

    The US cold plasma market was valued at $310.31 million in 2024 and is expected to grow to $509.51 million by 2029.

    What is the growth rate of the US cold plasma market?

    The US cold plasma market is growing at a compound annual growth rate (CAGR) of 10.4% from 2024 to 2029.

    What are the primary applications of cold plasma in the US healthcare market?

    In the US, cold plasma is primarily used for wound healing, surgical sterilization, infection control, and dermatological treatments across hospitals and specialty clinics.

    What factors are driving growth in the US cold plasma market?

    US market growth is driven by increasing adoption of minimally invasive treatments, FDA regulatory support, clinical validation, and expanding healthcare provider awareness of cold plasma efficacy.

    Which US healthcare settings are adopting cold plasma technology?

    US hospitals, surgical centers, specialty clinics, and wound care facilities are actively integrating cold plasma devices into their treatment protocols and standard care pathways.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Plasma Protein Therapeutic Association (PPTA), International Diabetes Federation (IDF),European Textile Services Association (ETSA), National Council of Textile Organizations (NCTO), Semiconductor Industry Association (SIA), International Journal of Plastic and Polymer Technology (IJPPT), International Journal of Engineering Research & Technology (IJERT and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global cold plasma market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the cold plasma market. The primary sources from the demand side include hospitals & clinics, physiotherapy clinics and home care settings. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global cold plasma market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players (who contribute at least 70-75% of the market share at the global level). Also, the global cold plasma market was split into various segments and sub-segments based on:

    • List of major players operating in the cold plasma   products market at the regional and/or country level
    • Product mapping of various cold plasma   manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from cold plasma (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70-75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global point-of-care  diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Data Triangulation

    After arriving at the overall size of the global cold plasma market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Plasma is the fourth state of matter. Cold plasma is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals and excited & ground-state molecules. It is an innovative and convenient alternative to traditional and conventional technologies used across a wide range of industries, including textiles, electronics & semiconductors, polymers & plastics, medical, cosmetic and food & agriculture.

    Stakeholders

    • Cold plasma manufacturers and distributors
    • Government and research organizations
    • Cold plasma application industries
    • Medical device manufacturing companies
    • Healthcare organizations
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Corporate entities

    Report Objectives

    • To define, measure, and describe the global cold plasma  market by industry, application, regime, and region
    • To provide detailed information about the major factors influencing the market growth (drivers, restraints, challenges, and opportunities)
    • To strategically analyze the regulatory scenario, pricing, value chain analysis, supply chain analysis, ecosystem analysis, technology analysis, Porter’s Five Forces analysis, and patent analysis
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To strategically analyze the market structure, profile the key players in the global cold plasma  market, and comprehensively analyze their core competencies
    • To track and analyze company developments such as acquisitions, partnerships, expansions, and product launches and approvals in the cold plasma  market

    Get the Full Cold Plasma Market Report

    Full forecast, segment splits, and company analysis for all Cold Plasma Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status